Highlights

[YONGTAI] Change In Director's Shareholding - WONG MEE YOW CHEEN @ LIEW MEE YOW CHEEN on 02-Jan-2004


Stock [YONGTAI]: YONG TAI BHD
Announcement Date 02-Jan-2004

Director's Particular:

Name WONG MEE YOW CHEEN @ LIEW MEE YOW CHEEN

Details of Changes:

Currency RM

Date of Change Type Number of Shares Price
22-Dec-2003 Acquired 18,000 1.150

Nature of Interest Direct
Shares Ordinary Shares of RM1.00 each
Reason Wong Mee Yow Cheen @ Liew Mee Yow Cheen exercised the options granted under the Company's Employees' Share Option Scheme and the new shares will be listed and quoted from 9.00 am., Tuesday, 6 January 2004.
Consideration RM1.15 per share

Total no of securities after change

Direct (units) 74,744
Direct (%) 0.19
Indirect (units) 20,091,729
Indirect (%) 50.36
Total (units) 20,166,473
Total (%) 50.55
Date of Notice 02-Jan-2004


  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

2170 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SCOMNET 2.300.00 
 KOTRA 3.180.00 
 UCREST 0.140.00 
 GENM-C73 0.0050.00 
 PUC 0.240.00 
 WILLOW 0.4250.00 
 EAH-WE 0.0150.00 
 IRIS 0.260.00 
 TOPGLOV-C79 0.4150.00 
 BTECH 0.4550.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
6. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS